Metanorm

Metanorm

metformin

Manufacturer:

Sea King Pharma

Distributor:

Sea King Pharma
Full Prescribing Info
Contents
Metformin hydrochloride.
Description
Each Film-Coated tablet contains: Metformin Hydrochloride 500 mg, or Metformin Hydrochloride 850 mg.
Action
Pharmacology: Pharmacokinetics: Metformin Hydrochloride is slowly and incompletely absorbed from the gastro-intestinal tract. A single 500-mg dose is reported to have a bioavailability of 50-60% (may be reduced in the presence of food). Plasma protein binding is negligible. It is excreted as unchanged drug in the urine. Plasma elimination half-life is reported to range from about 2 to 6 hours after oral administration.
Indications/Uses
Metformin Hydrochloride is a biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus. It is given to patients who are no longer responding to sulphonylureas, either alone or in combination with sulphonylurea.
Dosage/Direction for Use
Adult: Initial dose is 500 mg two or three times daily or 850 mg once or twice daily, with or after meals, gradually increased if necessary to a maximum of 2 to 3 g daily. Or as prescribed by a physician.
Special Precautions
Metformin Hydrochloride should not be used in insulin-dependent diabetes mellitus. Use in non-insulin-dependent diabetes mellitus is contraindicated in patients with ketoacidosis and in those with severe infection, stress, trauma and other severe conditions where it is unlikely to control hyperglycemia.
It should not be given in severe impairment of renal or hepatic function because of an increased risk of hypoglycemia.
It should not be given to pregnant or lactating women since it is excreted in breast milk.
It should not be used in patients with heart failure, recent myocardial infarction, dehydration, acute or chronic alcoholism or any other condition likely to predispose to lactic acidosis.
Use In Pregnancy & Lactation
It should not be given to pregnant or lactating women since it is excreted in breast milk.
Adverse Reactions
Metformin Hydrochloride causes gastro-intestinal adverse effects including anorexia, nausea and diarrhea; absorption of various substances including Vitamin B12 may be impaired. Patients may experience metallic taste and there may be weight loss.
Drug Interactions
Reduction in Metformin Hydrochloride dosage may be required in patients receiving Metformin Hydrochloride and Cimetidine concomitantly to reduce the risk of lactic acidosis.
Storage
Store at temperatures not exceeding 30°C.
MIMS Class
ATC Classification
A10BA02 - metformin ; Belongs to the class of biguanides. Used in the treatment of diabetes.
Presentation/Packing
FC tab 500 mg x 100's. 850 mg x 100's.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in